(Q45859642)

17 December 2017

editorial

0 references

title

Reversing liver cirrhosis: impact of gene therapy for liver cirrhosis (English)

1 reference

17 December 2017

0 references

0 references

Fujimoto J

1

1 reference

17 December 2017

Kaneda Y

series ordinal

2

1 reference

17 December 2017

publication date

1 March 1999

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

6

1 reference

17 December 2017

issue

3

1 reference

17 December 2017

page(s)

305-306

1 reference

17 December 2017

Hepatocyte growth factor gene therapy of liver cirrhosis in rats

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300885

Molecular cloning and expression of human hepatocyte growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300885

Transforming growth factor beta in tissue fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300885

Persistent gene expression in rat liver in vivo by repetitive transfections using HVJ-liposome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300885

Direct gene transfer into mouse muscle in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300885

Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300885

Inhibition of neoplastic development in the liver by hepatocyte growth factor in a transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300885

21 January 2018

Identifiers

DOI

10.1038/SJ.GT.3300885

1 reference

17 December 2017

Dimensions Publication ID

1025967707

0 references

1 reference

17 December 2017